New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
07:57 EDTMYGN, FMIMedicare rate cut would pressure Myriad, Foundation, says Leerink
Leerink says the final clinical lab fee schedule released by the CMS casts further doubt on the stability of breast cancer gene test pricing. The firm believes the proposed cut to the BRCA pricing, if valid, would present a material headwind to Myriad Genetics (MYGN) and also could further pressure reimbursement for Foundation Medicine's (FMI) FoundationOne test. Shares of Myriad closed yesterday down 9% while Foundation closed down 7% after the CMS announced its final clinical lab fee schedule.
News For MYGN;FMI From The Last 14 Days
Check below for free stories on MYGN;FMI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
09:59 EDTFMIOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AcelRx (ACRX) initiated with a Buy at Canaccord... Acorda Therapeutics (ACOR) initiated with a Hold at Canaccord... Alcobra (ADHD) initiated with a Buy at Canaccord... Benefitfocus (BNFT) initiated with a Market Perform at William Blair... Cameron (CAM) initiated with a Buy at Gabelli... Covanta (CVA) initiated with an Outperform at Macquarie... Foundation Medicine (FMI) initiated with a Market Perform at William Blair... Golub Capital (GBDC) initiated with an Outperform at Raymond James... Hanmi Financial (HAFC) initiated with an Outperform at Raymond James... Jazz Pharmaceuticals (JAZZ) initiated with a Buy at Canaccord... Kronos Worldwide (KRO) initiated with a Reduce at SunTrust... Magnum Hunter (MHR) initiated with a Hold at Maxim... Norwegian Cruise Line (NCLH) initiated with a Buy at Longbow... Plum Creek Timber (PCL) initiated with an Outperform at RBC Capital... RF Micro Devices (RFMD) initiated with a Market Perform at BMO Capital... SanDisk (SNDK) assumed with an Overweight at Piper Jaffray... Skyworks (SWKS) initiated with a Market Perform at BMO Capital... TransEnterix (TRXC) initiated with a Buy at Sterne Agee... TriQuint (TQNT) initiated with a Market Perform at BMO Capital... WebMD (WBMD) initiated with an Outperform at William Blair.
09:02 EDTFMIFoundation Medicine initiated with a Market Perform at William Blair
Subscribe for More Information
April 15, 2014
16:59 EDTFMIFoundation Medicine requests withdrawal of registration statement
The company has determined not to pursue the public offering to which the Registration Statement, No. 333-194711, relates at this time due to market conditions.
April 7, 2014
16:34 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
11:09 EDTMYGNMyriad Genetics advises prior BRACAnalysis news release be disregarded
Myriad Genetics advised that readers should disregard the news release, "Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis" issued April 7 by the company over GlobeNewswire.
10:16 EDTMYGNMyriad Genetics has a conference call hosted by JPMorgan
Subscribe for More Information
07:27 EDTFMIAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
05:48 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use